Dr. Webster is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
401 North Broadway Street
Weinberg BLDG
Baltimore, MD 21287Phone+1 410-955-8964Fax+1 410-367-2194
Education & Training
Johns Hopkins UniversityFellowship, Medical Oncology, 2017- Johns Hopkins UniversityResidency, Internal Medicine, 2011 - 2013
Stanford University School of MedicineClass of 2011
Certifications & Licensure
PA State Medical License 2024 - 2026
VA State Medical License 2021 - 2026
MD State Medical License 2014 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance Start of enrollment: 2017 Sep 05
Roles: Contact, Principal Investigator
- Post-transplant Flotetuzumab for AML Start of enrollment: 2022 Oct 20
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Recognition, prevention, and management of adverse events associated with asparaginase / pegaspargase treatment of acute lymphoblastic leukemia in adults: consensus of...Emily Curran, Marlise R Luskin, Houda Alachkar, Ibrahim Aldoss, Patrick W Burke
Haematologica. 2025-03-20 - A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B-cell or T-cell acute lymphoblastic leukemia: Results ...Neil D Palmisiano, Ju-Whei Lee, David F Claxton, Elisabeth M Paietta, Hassan Alkhateeb
Ejhaem. 2024-10-01 - 3 citationsAcute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.Bijal Shah, Ryan J Mattison, Ramzi Abboud, Peter Abdelmessieh, Ibrahim Aldoss
Journal of the National Comprehensive Cancer Network. 2024-10-01
Abstracts/Posters
- Final Clinical Results of a Phase II Study of High Dose Cytarabine Followed By Pembrolizumab in Relapsed/Refractory AMLJonathan Webster, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Coagulopathy, Hypoxemia, and Mortality Outcomes in Newly Diagnosed Acute Myeloid Leukemia with Hyperleukocytosis Treated with Large Volume LeukapheresisJonathan Webster, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
- Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients with Atrial Fibrillation: A Report from the GARFIELD-AF RegistryJune 1st, 2019
Grant Support
- Bispecific Antibody Maintenance Therapy after Allogeneic Bone Marrow TransplantJOHNS HOPKINS UNIVERSITY2023–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
